| Autor: |
J, Pillonel, D, David, R, Pinget, S, Laperche |
| Jazyk: |
francouzština |
| Rok vydání: |
2003 |
| Předmět: |
|
| Zdroj: |
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 9(5-6) |
| ISSN: |
1246-7820 |
| Popis: |
The epidemiological surveillance of autologous blood donors has been carried out in France since 1993. The number of autologous donors increased regularly from 1993 to 1997 but has decreased during the last three years to become less than 50,000 in 2000. The sex-ratio was stable over time (0.85 male for 1 female). The population of autologous donors grew older between 1993 and 2000: the proportion of those aged under 50 years old decreased from 29% in 1993 to 18% in 2000 while the proportion of those over 69 increased from 22 to 34%. Between 1993 and 2000, HbsAg prevalence decreased by a factor of 2.5 and HCV prevalence by a factor of 5. For HIV, a slight decrease was observed and the prevalence of HTLV was stable over time. In 2000, HCV prevalence (0.23%) was two times higher than HBsAg prevalence (0.12%), fifteen times higher than HTLV prevalence in Continental France (0.015%) and one hundred times higher than HIV prevalence (0.002%). The prevalence was similar in men and women for HCV, about two times higher in men than in women for HBsAg and three times higher for HIV. On the contrary, HTLV prevalence was about two times higher in women than in men. HBsAg and HCV prevalence rates were also calculated by age group. The prevalence rates for HBsAg increased up to the 30-39 age group among women and the 40-49 age group among men; then the rates decreased but were higher in men than in women. For HCV, while the prevalence increased continuously with age among women, a peak was reached for men in the 30-39 age group followed by a decrease up to the 50-59 age group and the prevalence was stable afterwards. The very low level of the current risk of transmitting viral infections by homologous transfusion and technical changes in autologous transfusion seem to be the two main factors that contributed to the recent decline in the number of autologous donors. The decrease in HBsAg and anti-HCV prevalence between 1993 and 2000 is multifactorial, but the drop observed for HCV is probably linked to a decrease in HCV prevalence of the general population over the last ten years. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect